Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.

European radiology experimental·2026
Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026
Same author

ASO Visual Abstract: Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis using Radiomics: An International Multi-center Cohort Study.

Annals of surgical oncology·2026
Same author

Correction: ASO Visual Abstract: Well‑Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes.

Annals of surgical oncology·2026
Same author

Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis Using Radiomics: An International Multi-center Cohort Study.

Annals of surgical oncology·2026
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Related Experiment Video

Updated: May 17, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.4K

Local Control in Soft Tissue Sarcomas.

Elizabeth H Baldini1, Alessandro Gronchi2

  • 1Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.

Hematology/Oncology Clinics of North America
|May 15, 2025
PubMed
Summary
This summary is machine-generated.

Soft tissue sarcoma (STS) requires expert diagnosis and multidisciplinary care. Treatment for extremity, trunk wall, and retroperitoneal sarcomas often involves wide surgical resection, with radiotherapy and medical therapy used in select cases.

Keywords:
Local controlOncologic resectionRadiation therapySoft tissue sarcomaUnplanned excision

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.1K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K

Related Experiment Videos

Last Updated: May 17, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.4K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.1K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Soft tissue sarcoma (STS) is a rare and diverse cancer group with over 100 subtypes.
  • Accurate diagnosis through expert pathology review is essential for effective treatment planning.
  • Management of STS often requires a multidisciplinary approach at specialized centers due to treatment complexities.

Purpose of the Study:

  • To emphasize the critical role of expert pathology in diagnosing soft tissue sarcomas.
  • To highlight the importance of multidisciplinary team discussions for optimal STS management.
  • To outline current treatment standards for different STS locations.

Main Methods:

  • Review of current diagnostic and treatment paradigms for soft tissue sarcoma.
  • Emphasis on the necessity of expert pathology confirmation.
  • Discussion of multidisciplinary care strategies and surgical approaches.

Main Results:

  • Expert pathology review is crucial for accurate STS diagnosis.
  • Multidisciplinary management at expert centers is strongly recommended.
  • Wide resection, with or without preoperative radiotherapy, is standard for most extremity and trunk wall STS.
  • Macroscopic complete resection is the standard for retroperitoneal sarcomas, with radiotherapy considered for specific subtypes.

Conclusions:

  • Accurate diagnosis and specialized care are paramount for soft tissue sarcoma patients.
  • Treatment strategies for STS vary based on tumor location and histology.
  • Integration of surgery, radiotherapy, and medical therapy is key in managing complex STS cases.